| Title: | Estimating disease prevalence in large datasets using genetic risk scores |
| Journal: | Nature Communications |
| Published: | 8 Nov 2021 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/34750397/ |
| DOI: | https://doi.org/10.1038/s41467-021-26501-7 |
| URL: | https://www.nature.com/articles/s41467-021-26501-7.pdf |
Publication 10588
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Clinical classification is essential for estimating disease prevalence but is difficult, often requiring complex investigations. The widespread availability of population level genetic data makes novel genetic stratification techniques a highly attractive alternative. We propose a generalizable mathematical framework for determining disease prevalence within a cohort using genetic risk scores. We compare and evaluate methods based on the means of genetic risk scores' distributions; the Earth Mover's Distance between distributions; a linear combination of kernel density estimates of distributions; and an Excess method. We demonstrate the performance of genetic stratification to produce robust prevalence estimates. Specifically, we show that robust estimates of prevalence are still possible even with rarer diseases, smaller cohort sizes and less discriminative genetic risk scores, highlighting the general utility of these approaches. Genetic stratification techniques offer exciting new research tools, enabling unbiased insights into disease prevalence and clinical characteristics unhampered by clinical classification criteria.</p>
10 Authors
- Benjamin D. Evans
- Piotr Słowiński
- Andrew T. Hattersley
- Samuel E. Jones
- Seth Sharp
- Robert A. Kimmitt
- Michael N. Weedon
- Richard A. Oram
- Krasimira Tsaneva-Atanasova
- Nicholas J. Thomas
Enabling scientific discoveries that improve human health